Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer
- PMID: 28421114
- PMCID: PMC5379099
- DOI: 10.1155/2017/3456264
Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer
Abstract
Epstein-Barr virus is a ubiquitous human herpesvirus whose primary infection causes mononucleosis, Burkett's lymphoma, nasopharyngeal carcinoma, autoimmune diseases, and gastric cancer (GC). The persistent infection causes malignancies in lymph and epithelial cells. Helicobacter pylori causes gastritis in human with chronic inflammation. This chronic inflammation is thought to be the cause of genomic instability. About 45%-word population have a probability of having both pathogens, namely, H. pylori and EBV. Approximately 180 per hundred thousand population is developing GC along with many gastric abnormalities. This makes GC the third leading cause of cancer-related death worldwide. Although lots of research are carried out individually for EBV and H. pylori, still there are very few reports available on coinfection of both pathogens. Recent studies suggested that EBV and H. pylori coinfection increases the occurrence of GC as well as the early age of GC detection comparing to individual infection. The aim of this review is to present status on coinfection of both pathogens and their association with GC.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- American Cancer Society Cancer Facts & Figures 2016. Cancer Facts Fig. 2016, 1–9, 2016.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
